|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,450.00 KRW | -6.71% |
|
-8.44% | -34.75% |
| 12-09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/06/25 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GC GENOME CORPORATION | Medical & Diagnostic Laboratories | -6.71% | -8.44% | -34.75% | -51.74% | - | 70.48M |  |  | |
- Stock Market
- Stocks
- A340450 Stock
- Charts GC Genome Corporation
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
